R. Moszczyński-Pętkowski

Pyrroloquinoline scaffold-based 5-HT6R ligands: Synthesis, quantum chemical and molecular dynamic studies, and influence of nitrogen atom position in the scaffold on affinity.

A. Bojarski, Rafał Kurczab, G. Satała, 2018, Bioorganic & medicinal chemistry.

Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties.

A. Bojarski, Rafał Kurczab, G. Satała, 2019, European journal of medicinal chemistry.

Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric Agonists

M. Nowotny, M. Wieczorek, Izabela Rutkowska-Wlodarczyk, 2021, Pharmaceuticals.

Esketamine inhaled as dry powder: Pharmacokinetic, pharmacodynamic and safety assessment in a preclinical study.

M. Wieczorek, M. Janicka, H. Ziółkowski, 2022, Pulmonary pharmacology & therapeutics.

2-Aminoimidazole-based antagonists of the 5-HT6 receptor - A new concept in aminergic GPCR ligand design.

A. Bojarski, Rafał Kurczab, G. Satała, 2019, European journal of medicinal chemistry.

Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil

T. Pietras, M. Markowicz-Piasecka, Maria Podsiedlik, 2020, Journal of enzyme inhibition and medicinal chemistry.

Synthesis and characterization of novel classes of PDE10A inhibitors - 1H-1,3-benzodiazoles and imidazo[1,2-a]pyrimidines.

F. Stefaniak, M. Wieczorek, Katarzyna Bazydło, 2018, European journal of medicinal chemistry.